As a seizure treatment, tezampanel would be unique among current offerings. The drug works by blocking certain receptors in the central nervous system, preventing excessive neurological activity. Most seizure medications today are benzodiazepines, which are thought to work in the opposite way: By reducing the activity of neurotransmitters in the brain.
Proniras currently has three full-time employees and is based in Accelerator’s Seattle headquarters. It is the seventeenth startup to join Accelerator’s portfolio.